Cannabis-Based Medicinal Products
Indication
Cannabis-Based Products for the management of patients with chronic pain
Cannabis-based medicinal products NG144
Black
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Musculoskeletal system
Background
This relates to the following drugs:
• Nabilone
• Dronabinol
• THC (delta-9-tetrahydrocannabinol)
• A combination of cannabidiol (CBD) with THC
Recommendation
LSCMMG Recommendation:
Black
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria
Supporting documents: